IFP Advisors, Inc - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,436
+530.1%
1,340
+168.0%
0.00%
Q1 2023$1,815
+15025.0%
500
-75.3%
0.00%
Q4 2022$12
-99.9%
2,023
-15.7%
0.00%
Q3 2022$9,0000.0%2,3990.0%0.00%
Q2 2022$9,0000.0%2,3990.0%0.00%
Q1 2022$9,0002,3990.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$7,000
+133.3%
1,324
+32.4%
0.00%
Q3 2017$3,0000.0%1,0000.0%0.00%
Q2 2017$3,000
+50.0%
1,0000.0%0.00%
Q1 2017$2,000
+100.0%
1,0000.0%0.00%
Q4 2016$1,0000.0%1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,0001,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders